Skip to content

Cannabis: all studies

Page 215 of 288: studies 2,141 to 2,150 of 2,874, newest first. Back to the cannabis overview

Research

Impact of Nitrous Oxide on Neuropsychiatric Impairment in Adolescents: A Scoping Review.

Cureus August 1, 2025 Vanessa C Cornelio, Gary Lail, Kimberly Go et al.

Nitrous oxide (N₂O) misuse represents a growing public health issue, particularly among adolescents and young adults, who use it recreationally. This scoping review investigates recent and foundational studies on the long-term neuropsychiatric effects associated with prolonged and frequent use of this volatile gas. Various clinical databases and journal archives, such as those of the Journal of...

DOI: 10.7759/cureus.89448 (opens in new tab) Full text (opens in new tab) Addiction medicine Inhalant use disorder Nitrous oxide toxicity

Becoming a Psychedelic User: Reflections on Howard Becker and the (Future) Sociology of Psychedelics

Sociology Compass August 1, 2025 Jarrett Robert Rose 1 citation

ABSTRACT Howard Becker's early research on drug use—from examining how one becomes a marijuana user to analyzing the social contexts of LSD experiences—was innovative and radical for its time. Today, the unfolding “second wave” of psychedelia continues to generate new insights into how to best curate the social contexts of psychedelic use and hone the experience for transformative and...

DOI: 10.1111/soc4.70096 (opens in new tab) Anthropology Psychoanalysis Epistemology

Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats.

The International Journal of Neuropsychopharmacology August 1, 2025 Klára Šíchová, Barbara Mallarino, Lucie Janeckova et al. 1 citation

Hexahydrocannabinol (HHC) is a new psychoactive substance known for its mind-altering effects and temporary legal status. It is widely used in parts of the Europe and United Kingdom as a legal alternative to ∆9-tetrahydrocannabinol, yet little research has explored its effects and safety. This study examined how HHC is processed in the body, its toxicity, and its impact on behavior in male...

DOI: 10.1093/ijnp/pyaf041 (opens in new tab) Full text (opens in new tab) Acute toxicity Behavior Hexahydrocannabinol Pharmacokinetics +1

Role of ketamine in the treatment of substance use disorders: A systematic review.

Journal of Substance Use and Addiction Treatment August 1, 2025 Reinhard Janssen-Aguilar, Shakila Meshkat, Ilya Demchenko et al. 12 citations

Substance Use Disorders (SUDs) involve diminished control, risky use, impaired social interactions, and physical dependence. Despite their global prevalence and burden, treatment options remain limited. Ketamine (KET), an NMDA receptor antagonist, may aid SUD treatment by modulating glutamatergic neurotransmission. This systematic review evaluates KET's role in SUD treatment. This review...

DOI: 10.1016/j.josat.2025.209705 (opens in new tab) Full text (opens in new tab) Sud Systematic review Addiction treatment Ketamine therapy +3

Strong increase in the number of intoxications involving psychoactive drugs among adolescents reported to the Dutch Poisons Information Center from 2014-2023.

International Journal of Drug Policy August 1, 2025 Ilze Mj Thoonen, Saskia J. Rietjens, Arjen Koppen et al. 1 citation

The use of psychoactive drugs has been increasing worldwide, with adolescents and young adults accounting for a large share of people who use drugs. To date, there is limited information on trends of intoxications with psychoactive drugs among adolescents, particularly with regard to New Psychoactive Substances (NPS). A retrospective study was performed from 2014-2023 to characterize...

DOI: 10.1016/j.drugpo.2025.104860 (opens in new tab) Full text (opens in new tab) Substance intoxication Drug trends Adolescent Illicit drugs +5

New psychoactive substances (NPS) identified in Canada: Results of the online NPS survey (2020–2023)

Emerging Trends in Drugs, Addictions, and Health July 27, 2025 Sophie Rymill, Lexy Candler, Pavitra Ramachandran et al.

Purpose and scope: New psychoactive substances (NPS) are a broad class of compounds that are typically designed to mimic illicit substances and circumvent legislative controls. It is often difficult to predict their toxicity and other health effects due to a lack of research and data. In this study, NPS are defined as substances that are not controlled under the Controlled Drugs and Substances...

DOI: 10.1016/j.etdah.2025.100178 (opens in new tab) Full text (opens in new tab) New psychoactive substance Nps Hallucinogens Controlled substances +2

Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.

Journal of Eating Disorders July 24, 2025 Sarah-Catherine Rodan, Noah Meez, Sophie Lloyd-Hurwitz et al. 2 citations

There are few effective treatments for eating disorders (EDs), and new interventions are urgently needed. The MEDication and other drugs For Eating Disorders ("MED-FED") survey investigated the lived experience of adults with EDs regarding their prescription and non-prescription drugs use. Psychedelic drugs were highly rated in this survey for their impact on ED symptoms and general mental...

Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: a qualitative-quantitative approach.

Consciousness and Cognition July 7, 2025 Jussi Jylkkä, Hilla Väyrynen, Enyu Lin et al. 3 citations

Both psychedelic substances and meditation have been proposed to facilitate personally meaningful and transformative experiences, with insights playing a central role. However, previous research has mainly relied on questionnaires, limiting the range of insights that can be identified. In this study, we recruited participants who provided narrative reports of insights in personally meaningful...

DOI: 10.1016/j.concog.2025.103901 (opens in new tab) Profound personal insights Transformative insights Deep insights Mystical revelations +8

Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice.

Journal of Psychopharmacology July 1, 2025 Julie A. Marusich, Cassandra Prioleau, Luli R Akinfiresoye 1 citation

Hexahydrocannabinol (HHC) recently appeared on the recreational drug market and is often sold as a legal replacement for Δ9-tetrahydrocannabinol (Δ9-THC). Users primarily consume HHC for recreational purposes, but adverse effects have been reported. Given the scant literature on HHC, additional research is needed to better understand its effects. The present study sought to determine whether...

DOI: 10.1177/02698811251330739 (opens in new tab) Full text (opens in new tab) Hhc Cannabinoid tetrad Delta-9-THC Drug discrimination +1

The Induction of Dissociative States: A Meta-Analysis.

Biological Psychiatry Global Open Science July 1, 2025 Benjamin Brake, Lillian Wieder, Natasha Hughes et al. 5 citations

Dissociative states, characterized by discontinuities in awareness and perception, occur in a diverse array of psychiatric disorders and contexts. These states have been experimentally modeled in the laboratory through various induction methods, but relatively little is known about the efficacy and comparability of different experimental methods. In this meta-analysis, we quantified...